beast labs retatrutide (GLP-3) Research Peptide Retatrutide (20mg) | Research Use

Clinical trials have shown it can help people lose up to 22.5% of their body weight

Glucagon-like Peptide-1 (GLP-1) Agonists in Clinical Practice This section will give in-depth information about the existing local and systemic options in the current treatment paradigm for all the potential indications, in which most pharmaceutical companies are actively evaluating their inhibitors

If youre curious about whether GLP-1s are right for you, our providers are here to guide you through every step with clarity, compassion, and clinical expertise.

GPCRs phase II ACCESS program also comprises a body composition study, assessing the effect of aleniglipron on body fat loss over a 40-week evaluation period, and an open-label extension study that is evaluating eligible patients from the ACCESS study for an additional 36 weeks